Loading viewer...
earnings
Format: PDF earnings
Immunic Therapeutics presents third quarter 2023 financial results and corporate updates as of November 14, 2023. The presentation covers financial and operating results, anticipated clinical milestones, and highlights for the immunotherapy development company. Immunic trades on NASDAQ under ticker IMUX.
earnings
23 Pages
Macquarie Technology Group
Sherritt Q1 2023 Earnings Call: Financial & Operational Results
earningsearnings
30 Pages
Sherritt International Corporation